Stock GNHAY VIFOR PHARMA AG
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Vifor Pharma AG Other OTC

Equities

GNHAY

US92674R1023

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Rhythm Biosciences Expands Executive Management Team, Registers Diagnostic Blood Test With New Zealand
MT
Vifor Pharma Announces Resignation of Abbas Hussain as CEO
CI
Landos Biopharma Appoints Gregory Oakes Chief Executive Officer
MT
Vifor Pharma Ag Announces Board Changes
CI
Vifor Pharma Group Appoints Two New Members to the Executive Committee
CI
Vifor Pharma Appoints GlaxoSmithKline Executive As Chief Commercial Officer
MT
Vifor Pharma Appoints Hervé Gisserot as Chief Commercial Officer and Member of the Executive Committee, Effective 17 January 2022
CI
Vifor Pharma CFO To Retire In December
MT
Vifor Pharma Announces Changes to its Executive Committee
CI
Vifor Pharma : Abbas Hussain Appointed as New Chief Executive Officer of Vifor Pharma
BU
Vifor Pharma Group Announces Chief Executive Officer Changes
CI
Vifor Pharma AG Announces Director Changes
CI
Vifor Pharma Announces Board Changes
CI
Vifor Pharma Announces Board Changes
CI
Vifor Pharma AG Approves Dividend, Payable on 20 May 2020; Announces Board Changes
CI
Vifor Pharma AG Announces Management Changes
CI
Vifor Pharma Appoints Lee Heeson as President International and Member of the Executive Committee, Effective February 1, 2020
CI
Vifor Pharma Reorganizes its Management Team
CI
Vifor Pharma Announces Management Changes
CI
Vifor Pharma Ltd. Approves Board and Committee Changes; Approves Dividend, Payable on 14 May 2019
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VIFN Stock
  4. GNHAY Stock
  5. News Vifor Pharma AG
  6. Insiders